19815 Bay Branch Rd
Andalusia, Alabama 36420
(334) 222-2523
HELPLINE: 1-877-530-0002



Facebook    

 

SCAMHC is an approved Mental Health site for the National Health Service Corps Loan Repayment program.  Find out the program details and see if you qualify by visiting: http://nhsc.hrsa.gov/

SCAMHC is an Equal Opportunity Provider and Employer and maintains a Drug-Free Workplace

 

 

 

 


powered by centersite dot net
Child & Adolescent Development: Overview
Resources
Basic InformationMore InformationLatest News
More U.S. Teens, Kids Seeking Mental Health Care in ERsAHA News: Overweight Kids at Higher Risk for Blood Clots as AdultsHow to Protect Your Kids From DrowningFewer Boys Are Suffering Head Injuries, But Rate Rises for GirlsWhen Can Kids Return to Play After a Concussion?One-Third of U.S. Kids Have Back Pain, Study SaysMany Parents Think Vaping Around Kids Is FineTime Change Tougher for Kids With Mental Health IssuesLargest Study Ever Finds No Link Between Measles Vaccine, AutismSocial Media 'Influencers' Can Get Kids Eating Junk FoodCalifornia Parents Are Getting Around Vaccine Law, Fueling Measles OutbreaksAlmost Half of Global Cases of Childhood Cancer Go UndiagnosedOne Plus of Texting, Social Media: Divorce Made Easier on KidsObesity a Heartbreaker for KidsGreen Space Good for Your Child's Mental HealthTaking a Bite Out of Food Ads Targeted to KidsGet Ready for Summer Camp -- and AllergiesMom's Prenatal Fish Oil Might Help Kids' Blood Pressure LaterToxins in Home Furnishings Can Be Passed on to KidsHealth Tip: 10 Ways to Encourage Kids to Eat HealthierCodeine: An Opioid Threat to KidsKid-Friendly Food Swaps Everyone Will LoveKeep Your Kids Safe From BurnsHealth Tip: Get Your Child to School on TimeDoes Bullying Start at Home?Opioids Overprescribed for Common Children's Fracture, Study SaysHalf of U.S. Kids With a Mental Health Disorder Don't Get TreatmentHealth Tip: Talk to Your Kids Early About Alcohol UseBouncing From 'Jump Park' Trampolines Into the ERHealth Tip: Prevent the Spread of Head LiceHealth Tip: Cook With Your ChildThe Lowdown on E-Cigarette Risks for KidsAs More U.S. Homes Have Handguns, Child Deaths RiseKids Exposed to Lead at Higher Odds for Mental Health Issues LaterMany Parents Wrong About What Prevents Colds in KidsMovie Violence Doesn't Make Kids Violent, Study FindsJunk Food Ads Target Minority Kids: StudyParents Often Unaware of Kids' Suicidal ThoughtsFiber: It's Not Just for AdultsAnimal Study Suggests Ritalin Won't Harm the HeartHealth Tip: Foster Healthy Hair Habits for KidsSkeletons Mature Earlier Now, Affecting Orthopedic TreatmentsNo Link Between Mom-to-Be's Diet, Baby's Allergy RiskBe Alert for Concussions in Young AthletesHealth Tip: Risk Factors for Stroke in KidsFoods That Can Lead to Obesity in KidsOpioid Overdose Deaths Triple Among Teens, KidsWhopping Numbers on Whooping CoughIs Juice on School Menus a Problem?More U.S. Kids Dying From Guns, Car Accidents
Questions and AnswersVideosLinksBook Reviews
Related Topics

ADHD: Attention Deficit Hyperactivity Disorder
Childhood Mental Disorders and Illnesses
Parenting

Animal Study Suggests Ritalin Won't Harm the Heart

HealthDay News
by -- Robert Preidt
Updated: Jan 9th 2019

new article illustration

WEDNESDAY, Jan. 9, 2019 (HealthDay News) -- Ritalin, a widely used stimulant drug to treat attention-deficit/hyperactivity disorder (ADHD), likely poses no risk of heart damage in children, new research in monkeys suggests.

The findings are "very reassuring," said the study's principal investigator, Dr. Steven Lipshultz.

Each year, more than 1.8 million children in the United States take drugs to treat ADHD. Concerns have been raised that Ritalin, Concerta and other forms of methylphenidate could harm children's hearts.

Some studies have reported an increase in sudden cardiac death among children taking methylphenidate or other stimulant drugs for ADHD.

But this new study found that five years of high doses of methylphenidate did not damage the hearts of 30 rhesus monkeys. That length of time is similar to how long children and adults would use the drugs.

"Even high-dose chronic [methylphenidate] stimulant therapy did not result in any evidence of abnormal structures or function in the hearts of the monkeys," said Lipshultz, chair of pediatrics at the University at Buffalo School of Medicine and Biomedical Sciences, in New York.

However, his team cautioned that the results of animal research are not automatically applicable to humans.

One ADHD specialist unconnected to the study agreed.

"The [animal] study cannot be automatically applicable to humans," said Dr. Victor Fornari, who directs child and adolescent psychiatry at Zucker Hillside Hospital in Glen Oaks, N.Y.

Still, the findings "provide compelling evidence of the cardiac safety of this important evidence-based treatment for ADHD," Fornari said.

About 10 percent of U.S. children have been diagnosed with ADHD and related disorders. Up to 70 percent of them take prescription stimulant drugs, so possible heart risks associated with the drugs are a major concern, study author Lipshultz said in a university news release.

The U.S. Food and Drug Administration has ordered some prescription stimulants to carry black box warnings stating that children with underlying heart disease should use these medications with caution.

In Canada, a stimulant drug was removed from the market after it was linked to a small number of sudden cardiac deaths. Sales of the drug later resumed.

"This controversy has persisted without answer," Lipshultz said. "Yet the number of prescriptions for these medications for children with ADHD continues to expand."

Another expert said the new findings should help ease concerns.

The study results "are overall re-assuring in terms of cardiac safety and long-term use of stimulants for ADHD in otherwise healthy individuals," said Dr. Andrew Adesman, chief of developmental and behavioral pediatrics at Cohen Children's Medical Center in New Hyde Park, N.Y.

However, he added that the study "does not address clinical concerns about the safety of stimulants in individuals with certain types of heart disease."

Therefore, "health care providers need to continue to screen children for cardiac problems prior to prescribing stimulant medications like Ritalin, Concerta or Adderall, since there are some individuals who may still be at increased risk for potentially serious heart problems if treated with stimulant medication," Adesman said.

Lipshultz noted that the findings are good news for another type of pediatric patient: young cancer survivors.

"I have cared for children and adolescents who have survived childhood cancer, who now are experiencing severe learning disabilities as a result of their cancer therapies. They become my patients because their hearts have been damaged, an unfortunate effect of the successful treatment of their childhood cancer," he said.

"Current recommendations state that children such as these, with underlying heart disease, should avoid chronic stimulant therapy because of the concern that it could further damage their hearts," he explained. "However, these prescription stimulants often allow these children to do much better with their learning progress."

The new findings suggest that, in many cases, these medications can be prescribed to these children as well, Lipshultz said.

The study was funded by the U.S. National Institutes of Health. It was recently published in the journal Pediatric Research.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more on ADHD.